Dmytro Spilka explains why UK biotech companies are receiving increasing levels of investment and why this trend is likely to continue.
List view / Grid view
Tiziana Life Sciences
12 September 2014 | By Tiziana Life Sciences
Tiziana Life Sciences announces the appointment of Professor Roberto Pellicciari to the Company’s Scientific Advisory Board and as a consultant to the Company...